OMDA

Omada Health

Stock NASDAQ – Stock Market Prices, News & Analysis

Fournisseur de solutions de santé numérique axées sur la prévention et la gestion des maladies chroniques.

$ 11.62
2.27 %

Omada Health

$ 11.62
2.27 %
OMDA

Fournisseur de solutions de santé numérique axées sur la prévention et la gestion des maladies chroniques.

Price history of Omada Health
Price history of Omada Health

Performance & Momentum

6 Months 45.85 %
1 Year 49.48 %
3 Years 49.48 %
5 Years 49.48 %
Momentum
79

Strategic Analysis

Omada Health • 2026

Omada Health Inc positions itself as a key player in digital health, specializing in the prevention and management of chronic diseases through an innovative digital platform. Its business model focuses on integrating digital to improve clinical outcomes while reducing healthcare costs, targeting payers and employers as primary clients.

Strengths
  • Recognized expertise in digital health and personalized management of chronic conditions
  • Service offering centered around prevention, promoting user engagement and risk reduction
  • Scalable digital platform adapted to the growing needs of American healthcare systems
Weaknesses
  • Severely degraded stock performance over the medium and long term, impacting investor confidence
  • Recent lack of significant news that could support a rebound or revitalization of the stock price
Momentum

The current momentum reflects a depressed dynamic with a persistent downward trend over several years. This context requires particular vigilance and primarily offers potential to investors seeking turnaround opportunities in the digital health sector, pending operational or strategic improvements to come.

Analysis performed today

Similar stocks to Omada Health

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone